Benzene
|
CAS
71-43-2
|
C6H6
|
RTECS
CY1400000
|
Synonyms & Trade Names
Benzol, Phenyl hydride
|
DOT ID & Guide
1114 / 130
|
Exposure Limits
|
NIOSH REL: Ca TWA 0.1 ppm ST 1 ppm See Appendix A
|
OSHA PEL: [1910.1028] TWA 1 ppm ST 5 ppm See Appendix F
|
IDLH
Ca [500 ppm]
See: 71432
|
Conversion
1 ppm = 3.19 mg/m3
|
Physical Description
Colorless to light-yellow liquid with an aromatic odor. [Note: A solid below 42°F.]
|
MW: 78.1
|
BP: 176°F
|
FRZ: 42°F
|
Sol: 0.07%
|
VP: 75 mmHg
|
IP: 9.24 eV
|
|
Sp.Gr: 0.88
|
Fl.P: 12°F
|
UEL: 7.8%
|
LEL: 1.2%
|
|
Class IB Flammable Liquid: Fl.P. below 73°F and BP at or above 100°F.
|
Incompatibilities & Reactivities
Strong oxidizers, many fluorides & perchlorates, nitric acid
|
Measurement Methods
NIOSH 1500, 1501, 3700, 3800; OSHA 12, 1005
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet (flammable)
Change: No recommendation
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations (See Appendix E)
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, nose, respiratory system; dizziness; headache, nausea, staggered gait; anorexia, lassitude (weakness, exhaustion); dermatitis; bone marrow depression; [potential occupational carcinogen]
|
Target Organs
Eyes, skin, respiratory system, blood, central nervous system, bone marrow
Cancer Site
[leukemia]
|
See also: INTRODUCTION
See ICSC CARD: 0015 See MEDICAL TESTS: 0022
|